hotspot -WSS

hotspot

author：explore 2025-09-03 14:38:55 - browse：63

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

WSS

AI models in health care face new federal disclosure requirements

Insmed lung disease drug hits target in key Phase 3 trial

Childbirth

Adam's Biotech Scorecard: Do Sarepta's exon

AI models in health care face new federal disclosure requirements

Addiction doctors spar with methadone clinics over legislation

Wikipedia

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Activists slam private health insurers over coverage restrictions

Patients' immediate access to test results puts radiologists in a bind

Hepatitis C has a cure — but many Americans still lack access to it

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Trump demands the U.S. pay no more for drugs than other countries … again

Report: NIH

As demand for Covid shots wanes, Moderna seeks its next success

Scientists successfully use ultrasound imaging to map brain activity

focus

Insmed lung disease drug hits target in key Phase 3 trial

AI models in health care face new federal disclosure requirements

Health insurers say they are turning to AI to cut costs, improve care

Startling documents reveal new facets of Sacklers' opioid empire

iTeos Therapeutics debuts first data on TIGIT

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

hotspot

hotspot

leisure time

hotspot